Global Ablation Technology Market Size to Reach USD 13.87 Billion in 2032 | Emergen Research

Increasing prevalence of cardiac disorders, such as atrial fibrillation, is a significant factor driving global ablation technology market revenue growth

Vancouver, Aug. 28, 2023 (GLOBE NEWSWIRE) — The projected size of the global ablation technology market is anticipated to reach USD 13.87 Billion by 2032, with a consistent annual revenue growth rate (CAGR) of 9.3% throughout the forecast period. This analysis, conducted by Emergen Research, highlights the substantial increase in market revenue. This growth can be attributed to the ongoing advancements in technology and the increased availability and accessibility of innovative ablation products.

An illustrative example of this trend is the introduction of the DIRECTSENSE Technology on June 1, 2020. This technology provides a means to observe the impact of Radiofrequency (RF) energy delivery during cardiac ablation treatments. Notably, this technology was officially launched in the United States. The RHYTHMIA HDx Mapping System, incorporating the DIRECTSENSE Technology, received approval from the U.S. Food and Drug Administration (FDA) in April. It stands out as the sole device capable of monitoring changes in electrical resistance (local impedance) near the tip of the INTELLANAV MiFi Open-Irrigated (OI) ablation catheter. This innovation empowers medical professionals with an additional method to assess the therapeutic effects of ablation procedures.

Request Free Sample Copy (To Understand the Complete Structure of this Report [Summary + TOC]) @ https://www.emergenresearch.com/request-sample/1704

A notable factor that is impeding the growth of market revenue is the availability of alternative treatment options. For example, apart from ablation procedures, there are various medications designed for the treatment of atrial fibrillation. Utilizing medications to regulate individuals’ heartbeats is a widely accepted method for addressing atrial fibrillation. These medications effectively lower heart rate, thereby enhancing its pumping efficiency. Some familiar alternatives encompass blood thinners, medications targeting heart rhythm irregularities, and drugs designed to manage heart rate fluctuations.

Emergen Research is Offering Limited Time Discount (Grab a Copy at Discounted Price Now) @ https://www.emergenresearch.com/request-discount/1704

Scope of Research

Major Companies and Competitive Landscape

The global ablation technology market is consolidated with a few large and medium-sized players accounting for majority of market revenue. Major players are deploying various strategies, entering into mergers & acquisitions, strategic agreements & contracts, developing, testing, and introducing more effective ablation technology services. Some major players included in the global ablation technology market report are:

• Medtronic
• Johnson & Johnson Private Limited
• Abbott
• Boston Scientific Corporation
• AngioDynamics
• ATRICURE
• CONMED Corporation
• Olympus Corporation
• Smith+Nephew
• Stryker

Strategic Development

• On 14 October 2022, C2 CryoBalloon Ablation System for management of Barrett’s Esophagus was introduced by PENTAX Medical, a pioneer in the healthcare sector for therapeutic and diagnostic endoscopy solutions. Barrett’s esophagus can now be treated in Canada in an innovative and effective manner as a result of C2 CryoBalloon Ablation System.
• On 11 January 2022, Affera, a provider of medical technology, reached a formal agreement under which Medtronic will acquire the company for USD 925 million. Through its portfolio of minority investments, Medtronic has been a strategic investor in Affera and now has a 3% stake in the company. This agreement is expected to broaden Medtronic’s selection of innovative cardiac ablation devices and accoutrements.

Direct Order Can Be Placed Through This Link [Exclusive Copy] @ https://www.emergenresearch.com/select-license/1704

Some Key Highlights From the Report

• On 11 January 2022, Medtronic signed a formal agreement for acquisition of Affera, a provider of medical technologies for USD 925 million. Medtronic has been a strategic investor in Affera through its portfolio of minority interests, and owns 3% of the company’s share. According to this deal, Medtronic will be able to provide a wider range of cutting-edge cardiac ablation tools and accessories.
• The Radiofrequency (RF) ablators segment is expected to account for largest revenue share during the forecast period. Need for radiofrequency ablators is rising as more innovative RF technologies are being adopted in healthcare, along with introduction of new products by major market participants. For instance, on 13 October 2022, according to Biosense Webster, Inc., a division of Johnson & Johnson MedTech, introduced HELIOSTAR Balloon Ablation Catheter, the first RF balloon ablation catheter.
• The Cardiovascular Disease (CVD) treatment segment is expected to account for largest revenue share during the forecast period. This is due to introduction of superior technology introduced by major market players globally and rising frequency of cardiac illnesses including atrial fibrillation. For instance, on 02 June 2021, CardioFocus and China Grand Pharmaceutical entered into a licensing and distribution agreement, to get regulatory approvals for HeartLight X3 catheter ablation technology in China.
• The North America market is expected to account for largest revenue share during the forecast period. This is due to increasing use of new technologies as well as better research and development for design of effective ablation products. For instance, on 20 September 2022, Stryker’s OptaBlate bone tumor ablation system (OptaBlate) received 510(k) approval from the U.S. Food and Drug Administration.

Browse Full Report Description + Research Methodology + Table of Content + Infographics@ https://www.emergenresearch.com/industry-report/ablation-technology-market

Emergen Research has segmented the global ablation technology market based on product, application, end-use, and region:

• Product Outlook (Revenue, USD Billion; 2019–2032)
  • Radiofrequency Ablators
    • • Temperature-Controlled Radiofrequency Ablators
      • Fluid-Cooled Radiofrequency Ablators
      • Robotic Catheter Manipulation Systems
  • Laser/Light Ablators
    • • Excimer Laser Ablators
      • Cold Laser Ablators
  • Ultrasound Ablators
    • • Ultrasonic Surgical Ablation Systems
      • High-Intensity Focused Ultrasound Ablators
      • Extracorporeal Shockwave Lithotripsy Systems
      • Magnetic Resonance-Guided Focused Ultrasound Ablators
  • Electrical Ablators
    • • Argon Plasma/Beam Coagulators
      • Irreversible Electroporation Ablators
  • Cryoablation Devices
    • • Tissue Contact Probes
      • Tissue Spray Probes
      • Epidermal & Subcutaneous Cryoablation Devices
  • Microwave Ablators
  • Hydrothermal/Hydromechanical Ablators
• Application Outlook (Revenue, USD Billion; 2019–2032)
  • Cardiovascular Disease Treatment
  • Cancer Treatment
    • • Liver Cancer
      • Kidney Cancer
      • Prostate Cancer
      • Lung Cancer
      • Bone Metastasis
      • Breast Cancer
  • Ophthalmological Treatment
  • Pain Management
  • Gynecological Treatment
  • Urological Treatment
  • Orthopedic Treatment
  • Cosmetic/Aesthetic Surgery
  • Others
• End-Use Outlook (Revenue, USD Billion; 2019–2032)                                           

• • Hospitals
  • Ambulatory Surgical Centers (ASCs)
  • Ablation Centers
  • Others

• Regional Outlook (Revenue, USD Billion; 2019–2032)
  • North America
    1. U.S.
    2. Canada
    3. Mexico
  • Europe
    1. Germany
    2. UK
    3. France
    4. Italy
    5. Spain
    6. Sweden
    7. BENELUX
    8. Rest of Europe
  • Asia Pacific
    1. China
    2. India
    3. Japan
    4. South Korea
    5. Rest of APAC
  • Latin America
    1. Brazil
    2. Rest of LATAM
  • Middle East & Africa
    1. Saudi Arabia
    2. UAE
    3. South Africa
    4. Israel
    5. Rest of Middle East & Africa

Curated Reports You Shouldn’t Miss: Dive In Now!

Cardiac Monitors Market, By Product Type (Holter Monitors, Event Monitors, and Others), By Modality (Wired Monitors and Wireless Monitors), By Application (Arrhythmia, Heart Failure, and Others), By End-Use, By Region Forecast to 2032

Flexible and Semi rigid Ureteroscopy Market, By Product (Flexible Ureteroscopes, Semi-rigid Ureteroscopes, and Others), By Application (Urolithiasis, Urinary Stricture, and Others), By Region Forecast to 2032

Arthroscopy Instruments Market, By Product (Arthroscopes, Fluid Management Systems, and Others), By Application (Shoulder Arthroscopy, Knee Arthroscopy, and Other Arthroscopy), By End-Use, and By Region Forecast to 2032

Peripheral Vascular Devices Market, By Product (Angioplasty Balloons, Angioplasty Stents), By Indication (Target Artery Instability (TAI)) By End-use (Hospitals and Clinics, Ambulatory surgical services), By Region Forecast to 2030

Dental Biomaterials Market, By Product Type (Metallic Biomaterials, Ceramic Biomaterials, Chromium Alloys, Polymeric Biomaterials, and Others), By Application, By End-Use, By Region Forecast to 2032

Hematology Analyzers and Reagents Market By Product & Service (Hematology Products & Services and Hemostasis Products & Services), By Price Range, By Application, By Usage Type, By End-Use, and By Region Forecast to 2032

Centesis Catheters Market, By Type (Small-Bore Centesis Catheters and Large-Bore Centesis Catheters), By Procedure (Paracentesis, Thoracentesis, Arthrocentesis, and Amniocentesis), By Application, By End-Use, and By Region Forecast to 2032

Nephritis Market, By Stage (Stage I, Stage II, Stage III & Stage IV, and Others), By Medication (Immunosuppressive Drugs, Corticosteroids, and Others), and By Region Forecast to 2032

About Emergen Research

Emergen Research is a market research and consulting company that provides syndicated research reports, customized research reports, and consulting services. Our solutions purely focus on your purpose to locate, target, and analyze consumer behavior shifts across demographics, across industries, and help clients make smarter business decisions. We offer market intelligence studies ensuring relevant and fact-based research across multiple industries, including Healthcare, Touch Points, Chemicals, Types, and Energy.

Contact Us:

Eric Lee

Corporate Sales Specialist

Emergen Research | Web: https://www.emergenresearch.com/

Direct Line: +1 (604) 757-9756

E-mail: sales@emergenresearch.com

Explore Our Japanese Version: Ablation Technology Market

Explore Our Blogs and Insights Section: https://www.emergenresearch.com/insights

Read our Press Release @ https://www.emergenresearch.com/press-release/global-ablation-technology-market